跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 66,399 条关于
“lower-risk myelodysplastic syndrome”
全部
66,399
临床试验
50,813
药物
371
机构
53
资讯
15,162
去年
FDA Grants Fast Track Designation to Rigel's R289 for Lower-Risk Myelodysplastic Syndrome
去年
ESA Treatment Shows Survival Benefit in Lower-Risk Myelodysplastic Syndromes
去年
Canakinumab Shows Promise in Treating Relapsed/Refractory Lower-Risk Myelodysplastic Syndromes
2年前
Halia Therapeutics Initiates Phase 2a Trial of First-in-Class NLRP3 Inhibitor HT-6184 for Lower-Risk Myelodysplastic Syndromes
去年
CHMP Recommends Approval of Geron's Rytelo for Lower-Risk Myelodysplastic Syndromes
去年
Novel Updates in Second-line Therapies for LR-MDS
9个月前
Five-Day Azacitidine Regimen Shows Superior Survival Outcomes in Lower-Risk MDS Patients
去年
Luspatercept Demonstrates Superior Efficacy in Frontline Treatment of Lower-Risk MDS
去年
Luspatercept Improves Quality of Life in First-Line Treatment of Anemia in Lower-Risk MDS
去年
Halia Therapeutics Completes Enrollment in Phase 2a Trial of Novel NLRP3 Inflammasome Inhibitor for Myelodysplastic Syndrome
第 1 页，共 1517 页
上一页
下一页
